Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury

A legfontosabb adatok

Ki végzi
Rebiscan, Inc.
Hol
Roanoke (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
200 fő, tervezett
Kezdés
2021. dec. 1.
Várható befejezés
2027. dec. 31.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • Head and Intraocular Trauma Tool
  • SCAT-5
A regiszteradat frissítve
2026. augusztus 12.

Ki vehet részt

Életkor
13 év – 45 év
Nem
Nők és férfiak

A regiszter feltételei, szó szerint

Mind a 22 feltétel megnézéseKevesebb

Ki vehet részt

  • Age 13-45 years
  • Presents to the facility within 2 weeks of head trauma
  • Able to provide informed consent; If minor, then able to provide parental consent and minor assent
  • Able to participate in the examination, including the ability to follow simple instructions
  • Fluency in English or Spanish

Ki nem vehet részt

  • Under the influence of alcohol or drugs
  • Previous eye surgery
  • Known eye movement disorder, including nystagmus
  • Known optic nerve disease, including papilledema or optic neuropathy
  • Known retinal disease, including macular degeneration or retinal degeneration
  • History of neurosurgery
  • History of stroke/brain hemorrhage, brain tumor, or epilepsy
  • Diagnosed dementia or cognitive impairment requiring assistance for daily living
  • Other condition(s) under the care of a neurologist
  • Psychiatric hospitalization in the last 90 days
  • Glasgow Coma Scale score of equal to or less than 13 at the time of study enrollment
  • Visual acuity known to be 20/200 or less in either eye
  • Known strabismus, amblyopia (lazy eye), or double vision
  • Known cataract
  • Any head trauma requiring medical attention from a physician within the last 6 months
  • Subject considered unsuitable for participation in this clinical trial by PI, treating clinician, or study research staff
  • Any minor brain injury regardless of loss of consciousness

Helyszínek itt: Egyesült Államok

  • Carilion Roanoke Memorial HospitalRoanoke, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 100 TBI patients and 100 controls.

A vizsgálat 2 csoportja

  • TBI Patients

    TBI participants 13 to 45 years of age, recruited from patients at a clinical research facility who present with head trauma. Clinical evaluation for the patient can be positive (target condition present) or negative (target condition absent) for mTBI. Enrollment is to occur within 2 weeks of the incident injury.

    Kezelés: Head and Intraocular Trauma Tool és SCAT-5

  • Controls

    Participants should not be part of the Intended Use Population. Subjects that present to the hospital, clinic or emergency department, either as a patient or non-patient, with no history of head trauma.

    Kezelés: Head and Intraocular Trauma Tool és SCAT-5

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. augusztus 12.